{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:51:35Z","timestamp":1793317895169,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2019B020230004"],"award-info":[{"award-number":["2019B020230004"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017689","name":"Guangdong Provincial People's Hospital","doi-asserted-by":"publisher","award":["DFJH201808"],"award-info":[{"award-number":["DFJH201808"]}],"id":[{"id":"10.13039\/501100017689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017689","name":"Guangdong Provincial People's Hospital","doi-asserted-by":"publisher","award":["DFJH201925"],"award-info":[{"award-number":["DFJH201925"]}],"id":[{"id":"10.13039\/501100017689","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870254"],"award-info":[{"award-number":["81870254"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002674","name":"Russian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2020B1111170011"],"award-info":[{"award-number":["2020B1111170011"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007162","name":"Guangdong Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007162","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ejphar.2023.175754","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T02:03:40Z","timestamp":1683857020000},"page":"175754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Sacubitril\/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats"],"prefix":"10.1016","volume":"952","author":[{"given":"Qian","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-wei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-an","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-yu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-juan","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-qiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-mei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175754_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2004.04.004","article-title":"Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance","volume":"102","author":"Abassi","year":"2004","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2023.175754_bib2","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.119.043155","article-title":"When it comes to defining the outcomes of catheter ablation of atrial fibrillation, an implantable monitor is a great place to start","volume":"140","author":"Calkins","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2023.175754_bib3","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.3389\/fphys.2018.01052","article-title":"Dispersion of recovery and vulnerability to Re-entry in a model of human atrial tissue with simulated diffuse and focal patterns of fibrosis","volume":"9","author":"Clayton","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejphar.2023.175754_bib4","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ejhf.799","article-title":"Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides","volume":"19","author":"D'Elia","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2023.175754_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.14740\/cr1073","article-title":"Upstream therapy for atrial fibrillation prevention: the role of sacubitril\/valsartan","volume":"11","author":"De Vecchis","year":"2020","journal-title":"Cardiol Res"},{"key":"10.1016\/j.ejphar.2023.175754_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ejhf.656","article-title":"Chronic heart failure as a state of reduced effectiveness of the natriuretic peptide system: implications for therapy","volume":"19","author":"Diez","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ejphar.2023.175754_bib7","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/HYPERTENSIONAHA.111.202309","article-title":"Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients","volume":"61","author":"Du","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2023.175754_bib8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/HYPERTENSIONAHA.117.08934","article-title":"Atrial fibrillation and hypertension","volume":"70","author":"Dzeshka","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2023.175754_bib9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0091270009343932","article-title":"Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi)","volume":"50","author":"Gu","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175754_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2023.175754_bib11","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.114.302226","article-title":"Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression","volume":"114","author":"Heijman","year":"2014","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175754_bib12","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/CIRCEP.115.002896","article-title":"Effects of wild-type and mutant forms of atrial natriuretic peptide on atrial electrophysiology and arrhythmogenesis","volume":"8","author":"Hua","year":"2015","journal-title":"Circ. Arrhythm Electrophysiol."},{"issue":"3","key":"10.1016\/j.ejphar.2023.175754_bib13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1517\/14656566.2015.1000300","article-title":"LCZ696 - a new paradigm for the treatment of heart failure?","volume":"16","author":"Joan Minguet","year":"2015","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2023.175754_bib14","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/eurheartj\/ehl360","article-title":"Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation","volume":"27","author":"Kistler","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2023.175754_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173120","article-title":"Sacubitril\/valsartan attenuates atrial electrical and structural remodelling in a rabbit model of atrial fibrillation","volume":"881","author":"Li","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175754_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12265-021-10137-5","article-title":"Sacubitril\/valsartan decreases atrial fibrillation susceptibility by inhibiting angiotensin II-induced atrial fibrosis through p-smad2\/3, p-JNK, and p-p38 signaling pathways","volume":"15","author":"Li","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ejphar.2023.175754_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.yjmcc.2020.01.012","article-title":"High hydrostatic pressure induces atrial electrical remodeling through angiotensin upregulation mediating FAK\/Src pathway activation","volume":"140","author":"Li","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175754_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117209","article-title":"High hydrostatic pressure induces atrial electrical remodeling through upregulation of inflammatory cytokines","volume":"242","author":"Li","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2023.175754_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pbiomolbio.2015.12.001","article-title":"Electrophysiological effects of natriuretic peptides in the heart are mediated by multiple receptor subtypes","volume":"120","author":"Moghtadaei","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.ejphar.2023.175754_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev-med-052915-015509","article-title":"Neprilysin inhibitors: emerging therapy for heart failure","volume":"68","author":"Owens","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2023.175754_bib21","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3858\/emm.2012.44.6.041","article-title":"Dendroaspis natriuretic peptide regulates the cardiac L-type Ca2+ channel activity by the phosphorylation of alpha1c proteins","volume":"44","author":"Park","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejphar.2023.175754_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.yjmcc.2009.08.030","article-title":"Involvement of Src in L-type Ca2+ channel depression induced by macrophage migration inhibitory factor in atrial myocytes","volume":"47","author":"Rao","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175754_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-152-2-201001190-00005","article-title":"Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study","volume":"152","author":"Schaer","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2023.175754_bib24","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2023.175754_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944708092111","article-title":"Atrial fibrillation and renin-angiotensin system","volume":"2","author":"Serra","year":"2008","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"10.1016\/j.ejphar.2023.175754_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.regpep.2008.06.006","article-title":"B-type natriuretic peptide (BNP) attenuates the L-type calcium current and regulates ventricular myocyte function","volume":"151","author":"Sodi","year":"2008","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2023.175754_bib27","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1540-8167.2005.00259.x","article-title":"Atrial natriuretic peptide has dose-dependent, autonomically mediated effects on atrial refractoriness and repolarization in anesthetized dogs","volume":"16","author":"Stambler","year":"2005","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ejphar.2023.175754_bib28","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1093\/europace\/euq284","article-title":"Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation","volume":"12","author":"Tayebjee","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.ejphar.2023.175754_bib29","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/HJH.0000000000002326","article-title":"Angiotensin-neprilysin inhibition confers renoprotection in rats with diabetes and hypertension by limiting podocyte injury","volume":"38","author":"Uijl","year":"2020","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2023.175754_bib30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCRESAHA.117.311402","article-title":"Hypertension and atrial fibrillation: doubts and certainties from basic and clinical studies","volume":"122","author":"Verdecchia","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2023.175754_bib31","doi-asserted-by":"crossref","first-page":"H823","DOI":"10.1152\/ajpheart.00986.2003","article-title":"Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function","volume":"286","author":"White","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2023.175754_bib32","series-title":"Sacubitril\/valsartan Attenuates Atrial Structural Remodelling in Atrial Fibrillation Patients","author":"Yang","year":"2022"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:22:51Z","timestamp":1762143771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923002650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":32,"alternative-id":["S0014299923002650"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175754","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacubitril\/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175754"}}